Search - tctmd.com

Displaying 741 - 760 of 1185

Sort: Relevancy | Date

News Daily News

Los Dispositivos Cardiovasculares son la Clase Más Amplia de Dispositivo Retirados por la FDA desde 2005

Yael L. Maxwell

April 03, 2014

News Daily News

Cardiovascular Devices Make Up Largest Class of FDA Device Recalls Since 2005

Yael L. Maxwell

April 03, 2014

Presentation

Assessment of Cardiovascular and Non-Cardiovascular Medical Device Recalls

Presenter: John C. Somberg

March 27, 2014

News Daily News

与华法林或阿司匹林相比，阿哌沙班更具成本效益

Caitlin E. Cox

February 26, 2014

News Daily News

Apixaban es Rentable comparado con Warfarina o Aspirina

Caitlin E. Cox

February 26, 2014

News Daily News

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Caitlin E. Cox

February 26, 2014

Presentation

Cost-Effectiveness of Apixaban vs Current Standard of Care for Stroke Prevention in A-fib Patients

Presenter: Paul Dorian

February 20, 2014

News Daily News

Una Escala del Riesgo Predice la Mortalidad a Largo Plazo tras PCI

Caitlin E. Cox

February 03, 2014

News Daily News

Risk Score Predicts Long-term Mortality After PCI

Caitlin E. Cox

February 03, 2014

Presentation

Risk Stratification for Long-term Mortality AfterPCI

Presenter: C. Wu

January 30, 2014

Presentation

Changes in Geographic Variation in Use of PCI for Stable Ischemic Heart Disease after COURAGE

Presenter: Arun V. Mohan

December 26, 2013

News Daily News

Más Gasto en Pacientes EAP No arroja Beneficio alguno en los Índices de Amputación

December 05, 2013

News Daily News

Higher Spending in PAD Patients Yields No Benefit in Amputation Rates

December 05, 2013

Presentation

Relationship Between Regional Spending on Vascular Care and Amputation Rate

Presenter: Philip P. Goodney

December 03, 2013

Presentation TCT 2013

Thoughtful Insights(9)

Presenter: Felix Mahfoud

November 01, 2013

Presentation TCT 2013

Thoughtful Insights(8)

Presenter: Dierk Scheinert

November 01, 2013

Presentation TCT 2013

Thoughtful Insights(7)

Presenter: Jennifer Tremmel

November 01, 2013

Presentation TCT 2013

Thoughtful Insights(3)

Presenter: William O'Neill

November 01, 2013

Presentation TCT 2013

Thoughtful Insights(2)

Presenter: Adrian Banning

November 01, 2013

Presentation TCT 2013

Thoughtful Insights

Presenter: David Faxon

November 01, 2013

Advertisement

Los Dispositivos Cardiovasculares son la Clase Más Amplia de Dispositivo Retirados por la FDA desde 2005

Cardiovascular Devices Make Up Largest Class of FDA Device Recalls Since 2005

Assessment of Cardiovascular and Non-Cardiovascular Medical Device Recalls

与华法林或阿司匹林相比，阿哌沙班更具成本效益

Apixaban es Rentable comparado con Warfarina o Aspirina

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Cost-Effectiveness of Apixaban vs Current Standard of Care for Stroke Prevention in A-fib Patients

Una Escala del Riesgo Predice la Mortalidad a Largo Plazo tras PCI

Risk Score Predicts Long-term Mortality After PCI

Risk Stratification for Long-term Mortality AfterPCI

Changes in Geographic Variation in Use of PCI for Stable Ischemic Heart Disease after COURAGE

Más Gasto en Pacientes EAP No arroja Beneficio alguno en los Índices de Amputación

Higher Spending in PAD Patients Yields No Benefit in Amputation Rates

Relationship Between Regional Spending on Vascular Care and Amputation Rate

Thoughtful Insights(9)

Thoughtful Insights(8)

Thoughtful Insights(7)

Thoughtful Insights(3)

Thoughtful Insights(2)

Thoughtful Insights

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content